- Home
- DYN vs FIHL Comparison
DYN vs FIHL Comparison
Compare DYN & FIHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- FIHL
- Stock Information
- Founded
- DYN 1984
- FIHL 2014
- Country
- DYN United States
- FIHL Bermuda
- Employees
- DYN N/A
- FIHL N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- FIHL
- Sector
- DYN Health Care
- FIHL
- Exchange
- DYN Nasdaq
- FIHL Nasdaq
- Market Cap
- DYN 1.9B
- FIHL 1.6B
- IPO Year
- DYN 2020
- FIHL 2023
- Fundamental
- Price
- DYN $13.15
- FIHL $17.09
- Analyst Decision
- DYN Strong Buy
- FIHL Hold
- Analyst Count
- DYN 14
- FIHL 6
- Target Price
- DYN $34.93
- FIHL $20.67
- AVG Volume (30 Days)
- DYN 2.2M
- FIHL 576.4K
- Earning Date
- DYN 11-11-2025
- FIHL 11-11-2025
- Dividend Yield
- DYN N/A
- FIHL 3.48%
- EPS Growth
- DYN N/A
- FIHL N/A
- EPS
- DYN N/A
- FIHL N/A
- Revenue
- DYN N/A
- FIHL $2,607,600,000.00
- Revenue This Year
- DYN N/A
- FIHL $21.24
- Revenue Next Year
- DYN N/A
- FIHL $4.94
- P/E Ratio
- DYN N/A
- FIHL N/A
- Revenue Growth
- DYN N/A
- FIHL 21.21
- 52 Week Low
- DYN $6.36
- FIHL $14.17
- 52 Week High
- DYN $37.08
- FIHL $21.32
- Technical
- Relative Strength Index (RSI)
- DYN 56.80
- FIHL 49.56
- Support Level
- DYN $12.65
- FIHL $17.00
- Resistance Level
- DYN $13.68
- FIHL $17.65
- Average True Range (ATR)
- DYN 0.67
- FIHL 0.32
- MACD
- DYN -0.16
- FIHL -0.07
- Stochastic Oscillator
- DYN 30.72
- FIHL 12.59
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About FIHL Fidelis Insurance Holdings Limited
Fidelis Insurance Holdings Ltd is a specialty insurer that leverages strategic partnerships to offer tailored insurance solutions. The company classifies its business into two segments, Insurance and Reinsurance. A majority of its revenue is generated from the Insurance segment, which comprises a portfolio of property, marine, aviation and aerospace, political risk, violence and terror, energy, cyber, and other insurance risks. The Reinsurance segment consists of an actively managed property reinsurance book, providing reinsurance and a limited amount of retrocession coverage across the world on a proportional or excess-of-loss basis. Geographically, the company derives its key revenue from the United Kingdom, followed by Bermuda and the Republic of Ireland.